Primary record
N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide,(2R,3R)-2,3-dihydroxybutanedioic acid
- 库存
- 5,629 克
- 纯度
- 98.4 %
- CAS
- 345627-80-7
化合物标识与属性
- CAS
- 345627-80-7
- PubChem CID
- 3025986
- SMILES
- CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3
- Canonical SMILES
- CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1
名称与同义词
- SNS-032
- 345627-80-7
- BMS-387032
- SNS 032
- BMS 387032
- Kinome_3820
- SNS-032 (BMS-387032)
- Tube004
- SNS032
- BMS387032
- SNS-032 (hydrochloride)
- AC1MHGD4
- RefChem:886481
- D0S5RC
- C17H24N4O2S2
- CHEMBL296468
- MFCD09833875
- cc-229
- CHEBI:91399
- MLS006011029
- SCHEMBL187401
- DTXSID50188100
- OUSFTKFNBAZUKL-UHFFFAOYSA-N
- 2-(Chloromethyl)tetrahydropyran
- BDBM5931
- GTPL5670
- orb1301119
- N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide
- BMS-387072
- SNS 032 [WHO-DD]
- cid_3025986
- CTK4H2598
- 345627-80-7 (free base)
- AMY2872
- DTXCID40110591
- EX-A054
- UNII-9979I93686
- BCPP000066
- HMS3295G09
- HMS3654G10
- N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
- ACT06674
- BCP01951
- ZINC3816409
- N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide
- ABP000845
- EBC-11329
- NSC767048
- NSC799362
- s1145
- AKOS015898717
- AN-3519
- C17-H24-N4-O2-S2
- CCG-264835
- CID3025986
- CS-0021
- DB05969
- FS16408
- N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide
- NSC-767048
- NSC-799362
- RL03281
- SB16651
- SDCCGSBI-0654348.P001
- BMS-3870032
- CID:3025986
- KS-0000063E
- SNS-032BMS-3870032
- (2R,3R)-2,3-dihydroxybutanedioic acid
- compound 21 [PMID: 15027863]
- NCGC00263167-01
- NCGC00263167-02
- tert-Butyl 6-Bromopyridin-2-ylcarbamate
- ?BMS-387032?
- 4CA-1169
- AC-26846
- AJ-45713
- AK113734
- AS-35116
- BC224785
- BMS-387032, SNS-032
- BP-14149
- HY-10008
- SC-84716
- SMR004702824
- SNS-032, BMS-387032
- SID:441532656
- AB0033696
- AB1008461
- LS-186036
- N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide
- SNS-032 - BMS-387032
- SNS-032(BMS-387032)?
- 9979I93686
- A1980
- A6078
- FT-0674612
- NS00069289
- SW219478-1
- X7382
- J1.905.362H
- A10850
- A20554
- W-5410
- EN300-7398299
- 627B807
- C484864
- N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide
- I09-1579
- 4-Piperidinecarboxamide, N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-
- BRD-K43389698-001-01-6
- BRD-K43389698-001-07-3
- BRD-K43389698-001-09-9
- Q27075347
- SNS-032, 345627-80-7
- 345627-90-9
- Z2037281190
- SNS-032(BMS387032)/SNS032,BMS-387032
- 345627-92-1
- SNS-032, 98.5%, a selective CDK2 inhibitor - 25MG 25mg
- N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-peridinecarboxamide
- N-[5-[ methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide
- N-[5-[(5-tert-butyloxazol-2-yl)methylsulfanyl]thiazol-2-yl]piperidine-4-carboxamide
- N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide;SNS-032
- N-[5-[[(5-tert-Butyl-2-oxazolyl)methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide
- N-[5-[[(5-tert-Butyloxazol-2-yl)methyl]thio]thiazol-2-yl]piperidine-4-carboxamide
- 4-Piperidinecarboxamide,N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-
- 56H
- 892-362-9
- N-(5-(((5-(1,1-DIMETHYLETHYL)-2-OXAZOLYL)METHYL)THIO)-2-THIAZOLYL)-4-PERIDINECARBOXAM
- N-(5-(((5-tert-butyl-1,3-oxazol-2-yl)methyl)sulfanyl)-1,3-thiazol-2-yl)piperidine-4-carboxamide
- n-(5-((5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl)-1,3-thiazol-2-yl)piperidine-4-carboxamide
- N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide,(2R,3R)-2,3-dihydroxybutanedioic acid
- N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide; SNS-032
- n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]-thio]-2-thiazolyl]-4-piperidinecarboxamide
- N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide L-tartaric acid salt (2:1)
- N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamideHydrochloride
- Piperidine-4-carboxylic acid [5-(5-tert-butyl-oxazol-2-ylmethylsulfanyl)-thiazol-2-yl]-amide
- SNS-032|||N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide